A. Ives et al., “Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis,” Science, 331:775-78, 2011. Free F1000 Evaluation The parasite Leishmania—which forms large, slow-healing ...

Many of these diseases exhibit diverse clinical manifestations, such as the cutaneous, visceral, or mucocutaneous forms of leishmaniasis, or the ocular, congenital, and neurotoxoplasmosis ...

Nearly one million people worldwide are plagued annually by cutaneous leishmaniasis, a devastating skin infection caused by the Leishmania parasite. Predominantly affecting vulnerable populations ...

This is the reality of leishmaniasis in Colombia and many other countries around the world." Maria Adelaida Gomez, microbiologist with CIDEIM and co-lead author of the study Read the full story here .

Findings from a new study could help doctors select more effective treatments earlier for patients suffering from leishmaniasis, a disfiguring skin infection. Nearly one million people worldwide ...

Biomarkers have been identified that can predict the success of treatment for cutaneous leishmaniasis, a parasitic skin disease affecting nearly one million people annually.

LAKKI MARWAT: Karak deputy commissioner Sahibzada Samiullah has asked the MOL Pakistan Oil and Gas Company to arrange anti-leishmaniasis injections for the health department to enable it to ...

Separately, Muthoni said more than 1,000 cases of leishmaniasis had been reported in the country, adding: "We already have 33 dead." Leishmaniasis, which is caused by a microscopic parasite spread ...

About 75% of patients had a baseline CLASI-A severity > 10 points, meaning at least moderate mucocutaneous inflammation. The advantage for the active treatment arms was even greater for CLASI-50 ...